1. Home
  2. EW vs HLN Comparison

EW vs HLN Comparison

Compare EW & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$86.18

Market Cap

45.5B

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$10.12

Market Cap

41.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EW
HLN
Founded
1958
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Specialties
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.5B
41.7B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
EW
HLN
Price
$86.18
$10.12
Analyst Decision
Buy
Hold
Analyst Count
20
1
Target Price
$95.83
N/A
AVG Volume (30 Days)
3.0M
10.2M
Earning Date
02-10-2026
07-31-2025
Dividend Yield
N/A
1.80%
EPS Growth
N/A
41.64
EPS
2.33
0.23
Revenue
$5,883,800,000.00
$15,096,588,575.00
Revenue This Year
$14.29
$1.51
Revenue Next Year
$9.68
$4.67
P/E Ratio
$37.32
$44.11
Revenue Growth
10.60
N/A
52 Week Low
$65.94
$8.71
52 Week High
$87.89
$11.42

Technical Indicators

Market Signals
Indicator
EW
HLN
Relative Strength Index (RSI) 56.38 65.44
Support Level $85.79 $10.05
Resistance Level $87.44 $10.16
Average True Range (ATR) 1.38 0.12
MACD 0.08 0.04
Stochastic Oscillator 78.25 94.27

Price Performance

Historical Comparison
EW
HLN

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: